Patent · US Active

Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK

US7759518B2 · kind B2 · utility

32Cited by

11References

4Claims

0Family size

Assignee

Ardea Biosciences, Inc · US

Inventors

Andreas Maderna · Stony Point, US
Jean-Michel Vernier · Laguna Niguel, US
Dinesh Barawkar · Lake Forest, US
Varaprasad Chamakura · Irvine, US
Hassan El Abdellaoui · Jamestown, US
Zhi Hong · Chapel Hill, US

Key dates

Filing date	Nov 25, 2008
Grant date	Jul 20, 2010
Priority date	—
Expiry date	Nov 25, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention concerns N-(2-arylamino)aryl sulfonamides, which are inhibitors of MEK and are useful in treatment of cancer and other hyperproliferative diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.